Term
|
Definition
-Adrenocortical insufficiency
-Adverse: Cushings, ulcers, glaucoma, fx, HTN |
|
|
Term
|
Definition
-Adrenocortical insufficiency
-Adverse: Cushings, ulcers, glaucoma, fx, HTN |
|
|
Term
|
Definition
-Adrenocortical insufficiency
-Adverse: Cushings, ulcers, glaucoma, fx, HTN |
|
|
Term
|
Definition
-Adrenocortical insufficiency
-Adverse: Cushings, ulcers, glaucoma, fx, HTN |
|
|
Term
|
Definition
-Adrenocortical insufficiency
-Adverse: Cushings, ulcers, glaucoma, fx, HTN |
|
|
Term
|
Definition
-Mineralocoricoid (aldosterone agent)
-Adverse: hypokalemia |
|
|
Term
|
Definition
-Mineralocorticoid antagonist
-Adverse: hyperkalemia, impaired function of endrogenous sex hormones |
|
|
Term
|
Definition
-Antithyroid agent (hyperthyroidism)
-Adverse: hypoparathyroidism |
|
|
Term
|
Definition
-Antithyroid agent (hyperthyroidism)
-Adverse: Hypersensitivity |
|
|
Term
|
Definition
-Antithyroid agent (hyperthyroidism)
-Adverse: swelling in the neck |
|
|
Term
|
Definition
-Nonselective beta blocker (hyperthyroidism)
-Adverse: cardiac failure |
|
|
Term
|
Definition
-Synthetic replacement of T4
-Adverse: hyperthyroidism |
|
|
Term
|
Definition
-Synthetic replacement of T3
-Adverse: hyperthyroidism |
|
|
Term
|
Definition
-Hypoparathyroidism, osteoporosis
-Adverse: hypercalcemia, cardiac issues, mood changes, renal failure |
|
|
Term
|
Definition
-Vitamin D analog
-Adverse: hypercalcemia, cardiac issues, mood changes, renal failure |
|
|
Term
|
Definition
-Increases bone formation; treats osteoporosis
Adverse: loss of appetite |
|
|
Term
|
Definition
-Paget disease, osteoporosis
-Adverse: esophagitis |
|
|
Term
|
Definition
-Paget disease, osteoporosis
-Adverse: esophagitis |
|
|
Term
|
Definition
-Osteoporosis
-Adverse: cardiac problems |
|
|
Term
|
Definition
-DM
-Adverse: hypoglycemia |
|
|
Term
|
Definition
-Oral antidiabetic agent; sulfonyreas
-Adverse: neurologic symptoms, hypoglycemia |
|
|
Term
|
Definition
-Oral antidiabetic agent; sulfonyreas
-Adverse: neurologic symptoms, hypoglycemia |
|
|
Term
|
Definition
-Oral antidiabetic agent; biguanide
-Adverse: lactic acidosis |
|
|
Term
|
Definition
-Oral antidiabetic agent; alpha-glucose inhibitor
-Adverse: GI |
|
|
Term
|
Definition
-Oral antidiabetic agent; thiaxolidinediones
-Adverse: back pain |
|
|
Term
|
Definition
-Oral antidiabetic agent
-Adverse: hypoglycemia, bronchitis |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| -Antibiotic-Adverse: toxicity |
|
|
Term
|
Definition
-Antibiotic
-Adverse: toxicity |
|
|
Term
|
Definition
-Antibiotic
-Adverse: increased sensitivity to light, discolor teeth and impair growth in kids |
|
|
Term
|
Definition
-Serious bacterial infections
-Adverse: bone marrow aplasia |
|
|
Term
|
Definition
-Antiobiotic
-Adverse: tendinopathy |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| -Enable healthy cells to resist infection from viruses |
|
|
Term
|
Definition
| -Antifungal/parasitic agent |
|
|
Term
|
Definition
| -Antifungal/parasitic agent |
|
|
Term
|
Definition
| -Antifungal/parasitic agent |
|
|
Term
|
Definition
| -Antifungal/parasitic agent |
|
|
Term
|
Definition
| -Antifungal/parasitic agent |
|
|
Term
|
Definition
| -Antifungal/parasitic agent |
|
|
Term
|
Definition
|
|
Term
|
Definition
| -Antifungal/parasitic agent |
|
|
Term
|
Definition
| -Akylating anticancer agent |
|
|
Term
|
Definition
| -Akylating anticancer agent |
|
|
Term
|
Definition
| -Antimetabolite (anticancer) |
|
|
Term
|
Definition
| -Antineoplastic antibody (cancer) |
|
|
Term
|
Definition
|
|
Term
|
Definition
-Mitotic inhibitor (plant alkaloid)
-Anticancer |
|
|
Term
|
Definition
| -Plant alkaloid (anticancer) |
|
|
Term
|
Definition
| -Advanced inoperable breast and prostate cancer |
|
|
Term
|
Definition
|
|
Term
|
Definition
-Estrogen antagonist
-Reduce tumor growth |
|
|
Term
|
Definition
| -Advanced, inoperable breast cancer in postmeopausal women |
|
|
Term
|
Definition
-Hair cell leukemia
-Kaposi |
|
|
Term
|
Definition
|
|
Term
|
Definition
-Off market
-Multiple myeloma tx |
|
|
Term
|
Definition
|
|
Term
|
Definition
| -Antimetabolite (anticancer) |
|
|
Term
|
Definition
|
|
Term
|
Definition
-Immunosuppressant
-Anticancer, alkylating agent |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
